BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33620575)

  • 1. Identification of oral squamous cell carcinoma markers MUC2 and SPRR1B downstream of TANGO.
    Sasahira T; Kurihara-Shimomura M; Shimomura H; Bosserhoff AK; Kirita T
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1659-1672. PubMed ID: 33620575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport and Golgi organisation protein 1 is a novel tumour progressive factor in oral squamous cell carcinoma.
    Sasahira T; Kirita T; Yamamoto K; Ueda N; Kurihara M; Matsushima S; Bhawal UK; Bosserhoff AK; Kuniyasu H
    Eur J Cancer; 2014 Aug; 50(12):2142-51. PubMed ID: 24889917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small proline-rich protein-1B is overexpressed in human oral squamous cell cancer stem-like cells and is related to their growth through activation of MAP kinase signal.
    Michifuri Y; Hirohashi Y; Torigoe T; Miyazaki A; Fujino J; Tamura Y; Tsukahara T; Kanaseki T; Kobayashi J; Sasaki T; Takahashi A; Nakamori K; Yamaguchi A; Hiratsuka H; Sato N
    Biochem Biophys Res Commun; 2013 Sep; 439(1):96-102. PubMed ID: 23954638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cell chymase promotes angiogenesis and lymphangiogenesis mediated by activation of melanoma inhibitory activity gene family members in oral squamous cell carcinoma.
    Kurihara-Shimomura M; Sasahira T; Shimomura H; Bosserhoff AK; Kirita T
    Int J Oncol; 2020 May; 56(5):1093-1100. PubMed ID: 32319583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of small proline-rich protein 1B (SPRR1B) as a prognostically predictive biomarker for lung adenocarcinoma by integrative bioinformatic analysis.
    Zhang Z; Shi R; Xu S; Li Y; Zhang H; Liu M; Zhu G; Chen C; Pan Z; Liu H; Chen J
    Thorac Cancer; 2021 Mar; 12(6):796-806. PubMed ID: 33501784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sushi Repeat Containing Protein X-linked 2 Is a Downstream Signal of LEM Domain Containing 1 and Acts as a Tumor-Promoting Factor in Oral Squamous Cell Carcinoma.
    Sasahira T; Kurihara-Shimomura M; Nishiguchi Y; Shimomura H; Kirita T
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RUNX3 plays a tumor suppressor role by inhibiting cell migration, invasion and angiogenesis in oral squamous cell carcinoma.
    Zhou WN; Du YF; Bai J; Song XM; Zheng Y; Yuan H; Zhang W; Zhang ZD; Wu YN
    Oncol Rep; 2017 Oct; 38(4):2378-2386. PubMed ID: 28765934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of oral cancer-associated fibroblasts in angiogenesis, lymphangiogenesis, and tumor invasion in oral squamous cell carcinoma.
    Lin NN; Wang P; Zhao D; Zhang FJ; Yang K; Chen R
    J Oral Pathol Med; 2017 Jan; 46(1):21-30. PubMed ID: 27229731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells.
    Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC
    Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression and prognostic significance of Mucin 13 and Mucin 20 in esophageal squamous cell carcinoma.
    Wang H; Shen L; Lin Y; Shi Q; Yang Y; Chen K
    J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C74-9. PubMed ID: 26323930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The serum biomarker chemerin promotes tumorigenesis and metastasis in oral squamous cell carcinoma.
    Lu Z; Liang J; He Q; Wan Q; Hou J; Lian K; Wang A
    Clin Sci (Lond); 2019 Mar; 133(5):681-695. PubMed ID: 30804218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular fibronectin 1 promotes VEGF-C expression, lymphangiogenesis and lymph node metastasis associated with human oral squamous cell carcinoma.
    Morita Y; Hata K; Nakanishi M; Omata T; Morita N; Yura Y; Nishimura R; Yoneda T
    Clin Exp Metastasis; 2015 Oct; 32(7):739-53. PubMed ID: 26319373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF/MET pathway.
    Chen ST; Kuo TC; Liao YY; Lin MC; Tien YW; Huang MC
    Oncogene; 2018 Nov; 37(46):6041-6053. PubMed ID: 29993037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MALDI imaging reveals NCOA7 as a potential biomarker in oral squamous cell carcinoma arising from oral submucous fibrosis.
    Xie X; Jiang Y; Yuan Y; Wang P; Li X; Chen F; Sun C; Zhao H; Zeng X; Jiang L; Zhou Y; Dan H; Feng M; Liu R; Chen Q
    Oncotarget; 2016 Sep; 7(37):59987-60004. PubMed ID: 27509054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
    Kono M; Watanabe M; Abukawa H; Hasegawa O; Satomi T; Chikazu D
    J Oral Maxillofac Surg; 2013 Oct; 71(10):1694-702. PubMed ID: 23809761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small proline-rich protein 1B (SPRR1B) is a biomarker for squamous metaplasia in dry eye disease.
    Li S; Nikulina K; DeVoss J; Wu AJ; Strauss EC; Anderson MS; McNamara NA
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):34-41. PubMed ID: 18172072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High mobility group box-1-inducible melanoma inhibitory activity is associated with nodal metastasis and lymphangiogenesis in oral squamous cell carcinoma.
    Sasahira T; Kirita T; Oue N; Bhawal UK; Yamamoto K; Fujii K; Ohmori H; Luo Y; Yasui W; Bosserhoff AK; Kuniyasu H
    Cancer Sci; 2008 Sep; 99(9):1806-12. PubMed ID: 18616526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
    Liang X; Yang D; Hu J; Hao X; Gao J; Mao Z
    Anticancer Res; 2008; 28(3A):1659-66. PubMed ID: 18630523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
    Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.